$834.00 *NOT AVAILABLE to AL, ID, AK, HI This past June, the US Food and Drug Administration approved GLP-1, a glucagon-like peptide 1 receptor agonist, for chronic weight management, based on results from the four 68-week STEP (Treatment Effect in People with obesity) trials
Reclaim your youth, elevate your daily energy, and finally discover the absolute best version of yourself with us right now here in Texas
Subsequent studies and patents from the same group of researchers showed that a 15 amino acid peptide derived from the N-terminus of BPC, now known as BPC 157, has many of the same effects as the entire protein
Medical Weight Loss Financing to Avoid Upfront Costs
They are given by subcutaneous route due to increased efficacy and the ability to avoid first-pass metabolism
Heres what you get with us and what you wont find anywhere else